Search Results 121-130 of 16817 for Selective estrogen receptor modulator
Participation eligibility · Participants must be female and have Stage I, II, or III hormone receptor positive breast cancer based on clinical or pathologic ...
Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you ...
... receptor positive, estrogen receptor-positive, human epidermal growth receptor-2 negative metastatic breast cancer after progression on previous endocrine ...
... hormone receptor positive breast cancer with plan to continue medical OFS for at least the next 12 months. ECOG Performance Status (PS) 0, 1 or 2 (Appendix ...
Estradiol vaginal gel and ring are also used to treat moderate to severe hot flashes and other symptoms of menopause or low amounts of estrogen. The hormone ...
Pertuzumab and trastuzumab are monoclonal antibodies and forms of targeted therapy that attach to a receptor protein called human epidermal growth factor ...
Has a histologically and/or cytologically confirmed diagnosis of estrogen-receptor positive breast cancer by local laboratory and has HER2 negative breast ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.